Related Experiment Video
Updated: Aug 11, 2026

Guidelines for Elective Pediatric Fiberoptic Intubation
Published on: January 17, 2011
Insights
Midazolam is a safe and effective anesthetic induction agent for children over 8 years old, acting faster than in adults. It offers advantages over diazepam due to its water solubility and ease of administration.
Area of Science:
- Anesthesiology
- Pediatric Medicine
- Pharmacology
Background:
- Intravenous midazolam is used for anesthesia induction.
- Diazepam is a comparable anesthetic agent.
Purpose of the Study:
- To evaluate the efficacy and safety of midazolam for anesthesia induction in children over 8 years old.
- To compare midazolam's effects with diazepam in pediatric patients.
Main Methods:
- A randomized clinical trial involving 100 children over 8 years old.
- Intravenous midazolam was administered for anesthesia induction.
- A control group received diazepam for anesthesia induction.
Main Results:
- Midazolam demonstrated similar actions to diazepam in children.
- Midazolam exhibited a faster onset of action in children compared to adults.
- Circulatory, respiratory effects, and postoperative amnesia incidence were comparable to adult data.
- Postoperative vomiting occurred in 1% in the recovery room and 32% over two days.
- No adverse effects were noted in laboratory investigations.
Conclusions:
- Midazolam is a satisfactory induction agent for pediatric anesthesia.
- Its water solubility and safe injection without dilution present a significant advantage over diazepam.
Abstract:
Midazolam was given intravenously to 100 children over the age of 8 years to induce anaesthesia and a similar control group was anaesthetised with diazepam. The actions of midazolam in children were found to be similar to those of diazepam. Midazolam acted more quickly in children than has been reported in adults. The effects on the circulation and respiration, and the incidence of postoperative amnesia were similar in children to that which has been reported in adults. The incidence of postoperative vomiting after midazolam was 1% in the recovery room and 32% during the first two postoperative days. Laboratory investigations did not demonstrate any adverse effects. Midazolam has a considerable advantage over diazepam being water soluble and injectable safely without dilution. This clinical trial suggests that midazolam is a satisfactory induction agent for children.
More Related Videos
Related Concept Videos
Parenteral Anesthetics: Overview
Inhalational Anesthetics: Overview
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Drug Dosing: Infants and Children

